Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well said
My bad I did not read the date. I'm more of a morning person!
Sneaky shit behind the scenes.. WTF Come on guys pull out of this mess I am in no mood to loose money. I'm here to buy a bigger boat! LOL Guess we are gonna have to wait and see what happens this week. Our product is great I love it.
http://www.thehotpennystocks.com/articles/ubiquitech-software-corp-otcmktsubqu-transforms-itself-into-a-pot-stock/
Anyone ever think that bad reviews can be written by competitors? Happens all the time to knock em down if they are scared the product they sell lacks the quality. Shipping delays can be due to excessive orders and back log. Seems that is seldom ever mentioned.
Not sure how many are real businessmen on here but it takes years to build a solid business with a solid core foundation.
No Big $$$ happens overnight but the lottery! $$UBQU$$
All the Opiod stocks are getting slammed I just heard on CNBC some outrageous number for a lawsuit... $100 million bucks. OUCH.
My guess is sooner than later someone is gonna pay attention to this little gem. Just to cover some butt and say that they are reformed opiod pushing addict AKA Big Pharm.
https://ih.advfn.com/stock-market/USOTC/north-american-cannabis-USMJ/stock-news/78893401/pura-rated-bullish-following-news-with-kaly-on-1st
Here is some news related to what we bottle
HMPL That works nicely. i just checked and it appears to be available.
Nice!! Go UBQU soon to be Hemplife Today. Wonder what the symbol will be?
Hope all this comes with a brand spanking new share reduction for a sweet little present. Dreaming of course but what will the new symbol be?
Yummmy is that an organic burger that makes you SING loud when you dump it or when you eat it all up at these cheap prices?
I'm hoping for something positive cause I am still downing 80% of this crap burger after making a killing last year.. why did I go back for a second bite?
and right after I post.. email! NEWS LOL I'll leave it up for my sarcasm.
https://ir.singlepoint.com/press-releases/detail/163/singlepoint-looks-ahead-to-2019-as-major-reform-of-hemp
Hmmmm any good math people?
Hehehe we have over 1.5% of the market according to the chart... how much revenue in sales is that for 2018 and projected for 2019?
MORE THAN THE CURRENT MARKET CAP!!!!!!!!
AhWoooooo AhWooooooo AhWooooo AhWoooo Ghost is Howling at the moon
Hemplife is #12 on the list. We are in the top 20.
https://realmoney.thestreet.com/investing/stocks/farm-bill-passes-hemp-companies-will-be-big-winners-14808547?puc=yahoo&cm_ven=YAHOO&yptr=yahoo
So far just the 250mg bottle that comes in the starter pack which is 10mg per serving or dropper full.
I've done a lot of reading about the mg contents and decided to start off with lower dosages. 20-50 mg a day is low for me I need more like 50-100mg or more. My other neighbor said a full dropper was too much for her but loved the "even keel" feeling she had and was excited about the product. I will take that as good feedback.
Make sure you read about and the dosages and CBD/MG content. What you see on the label is the MG content not the dose. The dose is listed as the MG dosage per ML's on the dropper listed on the back of the bottle.
For example the CannazAll 250MG bottle has a 1.0 ML dropper so each dose is 10MG with about 25 servings per bottle. Get a magnifying glass to read it, very small print or I have really bad eyes.
Lots of great info about dosages, drug testing, benefits, scientific studies and more. It's fascinating and a total wonder this plant has been banned for a 100 years.
I was chatting with a young man last night and had one bottle in my truck.. easy $30 bucks! Pretty sure he will be back he talked about a few friends who wanted to try it.
I'm just talking about how it makes me feel and it's selling. Go figure. :)
In my 30+ years of business this has to be the only one I have ever participated in that the product sells itself by word of mouth. Outside of my restaurants and we used hemp flour back in 2008!
I got my start pack this week. Just by word of mouth in my area I have sold 5 bottles with more people wanting it just waiting on me to deliver.
So far those reporting back are with amazing results. I know it's a small test pool but it's 100% positive. I'm glad I made the decision to be an Ambassador. I might be the first CannazAll dealer in my area :) Sweet!
On the second night my sleep was incredible, 2 hrs longer and less tossing and turning. My overactive mind was noticeably calmer. I cannot remember the last time my sleep was so peaceful.
My aches are not so bad either. I have stage 3 degenerative neck and spinal issues and a whole bunch more aches and pains from being stupid as a youth and a boat load of other health issues I am hoping CBD helps with. Any relief without a prescription is welcome. My PT
Dr has interest in it and that is awesome. Open minds in Texas!
This will do well and I think its already doing better than most think. IMO this is just the beginning of an interesting future with legal CBD, industrial hemp and for sure UBQU.
Hemplife recently started the SEO campaign, it takes a few months to kick in. I own well over 2 mil shares and am here for a very very long time. Feel free to sell me cheap cheap shares even at this 1.1 bil share count. It's the market cap! I'd love to reach 10 mil+ before the end of the year and the boom from the farm bill.
UBQU = $$$$
How can this not make Alkame millions? We bottle for them. There has to be something big brewing behind the scenes...
What is Santa Earkle going to bring us for Christmas? Lots of Money I hope!!
Dallas, TX -- December 4, 2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today released an update on its end of year sales drive to reach or exceed $1 million in sales for 2018 and to add insight into the 2019 anticipated sales growth.
The company recently reported its revenue for the nine months ending September 30, 2018 at $868,300 representing an increase of over 400% since the company reported $168,000 for the same period last year. The company also realized a 50% profit margin reporting a $448,800 bottom line for the nine months ending September 30, 2018. Management believes the $1 million in annual sales benchmark is within reach for 2018 and continues pushing to insure success. The company today announced signing a new distributor, Savannah Distributing Company, opening up sales of Puration’s EVERx CBD Sports Water for the first time within the Southeast United States. Management anticipates additional geographic distribution expansion announcements before the end of the year.
Recent analyst coverage of Puration included a $3 million estimated 2019 revenue projection. Following the analyst coverage, Puraiton announced a $1 million agreement to produce a new private labeled CBD infused bottled water for a health care industry firm. With what appears to be the imminent legalization of hemp and hemp-derived CBD in the United States under the 2018 Farm Act, demand for CBD infused beverages could expand rapidly.
“If the bill makes it through Congress and is signed by President Trump, as widely expected, industrial hemp should be legal on Jan. 1, 2019. If this occurs, the U.S. market for hemp -- and its derivatives -- is expected to soar. The hemp-derived CBD market is projected to rocket from about $591 million this year to $22 billion by 2022, according to the Brightfield Group. That's a whopping 37-fold increase in just four years!” (See Full Article)
With Puration’s experience and expertise in the production and sales of CBD infused beverages, combined with the potential behind the legalization of hemp and hemp-derived CBD, management anticipates the growth of private label CBD infused beverages next year could be substantial. The company’s existing $1 million private label agreement could just be the beginning.
Puration has the sole license for beverage production of U.S. Patent No. 9,199,960 entitled 'METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT'. The patent is owned by Puration partner Kali, Inc. (USOTC: KALY) and Kali is currently working with Puration in the formulation of multiple extract concentrates that would enable Puration to produce a variety of private label CBD beverages with different CBD concentrates.
For more information on Puration, visit https://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Read between the lines from October... this partner is Generex.
HydroHealth CBD High Alkaline Health is the product.
The cat is out of the bag and was announced. We know who it is. This is for REAL and gonna be flipping exciting to be on this rocket ship ride.
Once the public realizes who bottles what they will be chasing a long time.
As for late filings.. Uh they are almost caught up. Lots of SEC filings say that 2014-2015 are filed and only a 10k for 2016. That's not very delinquent for what has happened behind the scenes. It does not concern me at all. Think of it as a buying opportunity if you have ammo.
Puration Inc Initiates Order with Co-Packer and Partner Alkame Holdings For All New Beverage For Cannabis Sector
PRESS RELEASE GlobeNewswire
Oct. 30, 2018, 12:53 PM
DALLAS, Oct. 30, 2018 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced initiating its first order with co-packer and partner Alkame Holdings, Inc. (USOTC: ALKM), for an all new cannabis sector beverage. The order is to fulfill the initial production of a new beverage business Puration is acquiring. Puration recently announced a letter of intent regarding the pending acquisition and today, management indicates the acquisition is imminent. “The name of the target acquisition has been kept under wraps for reasons that will soon be clear,” said Brian Shibley, CEO of Puration. “Alkame has been instrumental in the design of our first cannabis sector beverage, EVERx. We have long been in the works with Alkame on this second beverage we are today initiating the order on to produce. Alkame is instrumental in the formulation.”
Puration plans to publish an online presentation on Friday, November 2, 2018 detailing the new product line and corresponding imminent acquisition.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Fun Fact = Cash in Pocket...
Alkame Holdings already has its foot in the door overseas for all those CBD drinks and other co-packed products with Bell Foods International.
I think that equals INTERNATIONAL DISTRIBUTION Just sayin. Think beyond Canada.
Well here is something you may not know.. if you happen to wash it or drop it in the water it will dry out and continue to work. So far 2 have survived and came back on within 2 days. Glad I did not toss them.
I am long and not happy about the FDA I did post on their social media my results. My Opinion is give CVS some time. The role out is still in its early stages.
GTLA
How many ambassadors are followers? I noticed that as soon as the Trademark announcement a bunch of domains got snagged!! Looks like this is going to be taking off like a rocket IMO.
I got mine! Gonna have to wait and see what it is. GTLA Happy Hemping
GTP you are so right
That might be the Phoenix Rising! IMO
I think I might be able to retire soon!
Pura's co-packer!!!!!!!!!
“Subject to testing and corresponding regulatory approvals, we’re targeting a million-bottle launch of Generex CBD HydroHealth Water in 2019,” said Joseph Moscato, Generex President & Chief Executive Officer. “Given the network of pharmacies Generex owns itself, we are confident we can achieve if not exceed our million-bottle launch target. Puration’s experience and the caliber of Puration’s underlying extraction technology combined with the recently updated production facilities of Puration’s co-packer, are instrumental in Generex’s plan to rapidly launch NuGenerex CBD HydroHealth Water.”
Date: November 30, 2018
Generex Biotechnology Top-Line and Overall Valuation Bolstered By New Acquisitions and Puration Inc CBD Beverage Deal
Symbols: GNBT, PURA
Miramar, FL -- November 30, 2018 -- InvestorsHub NewsWire -- Generex Biotechnology Corp. (USOTC: GNBT) today announced that Goldman Small Cap Research issued a research update on the Company. The report reviews recently announced acquisitions and a potentially lucrative agreement with Puration, Inc. (USOTC: PURA) To view the update report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com.
Goldman Small Cap Research Report Highlights
In the Opportunity Research update, analyst Rob Goldman discusses Generex’s recent events and exciting upcoming opportunities that lie ahead.
Goldman noted, “Since our coverage initiation earlier this month, GNBT has announced a series of deals that should serve as a precursor to revenue and valuations gains in 2019. The Company continues to execute on its strategy to become a nationwide, integrated, end-to-end health care firm. GNBT has signed a LOI with 2 firms, in which the Company will own 51%. Both deals should close this quarter and a tender for the remaining 49% could occur next year. These transactions will give GNBT exposure to the $23B wound care market via a platform device that is cleared for 17 indications, including diabetic ulcers, and the multi-billion-dollar ulcerative colitis market via a pending 510(k) De Novo submission and trial. Each of these categories represents favorable valuations, which could be unlocked, beginning next year.”
“The Company’s new CBD Product Agreement with Puration is game-changing. GNBT will be introducing NuGenerex CBD HydroHealth High Alkaline Water to its patient population and ever-growing pharmacy network. This high value new offering will be infused with custom CBD extracts as therapies for symptoms of specific health issues. “
Goldman concluded, “The aforementioned business development events projects affirm our favorable outlook on these shares and we continue to expect a higher overall valuation ahead for GNBT.”
About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.
Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
This press release contains excerpts of our most recently published non-sponsored company research report on Generex Biotechnology Corp. which carries a rating and a price target. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from Generex Biotechnology Corp. (“the Company”) authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission http://www.sec.gov.
Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Goldman Small Cap Research was not compensated for the production or distribution of this update or press release by any company mentioned in this update or press release. On a year-to-date basis, Goldman Small Cap Research was compensated $5500 by Puration, Inc. the Company for research and distribution services.
About Generex Biotechnology Corp. (OTC - GNRX) Generex Biotechnology Corp. is a strategic, diversified healthcare holdings company with offerings in a variety of services, diagnostics, medical devices, and pharmaceutical development. The Company’s direct-to-patient services support its strategy of all-inclusive access to doctors, diagnostics, therapeutics, and additional health-related services to greatly improve the patient experience in receiving care. Generex’s management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care. The Company also is engaged in clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics and its proprietary buccal administration of insulin.
Puration, Inc. is a leading Texas-based, CBD-infused beverage provider.
For more information, please visit: www.Generex.com
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
View source version on Investorshub.com: https://ih.advfn.com/p.php?pid=nmona&article=78795295
That's great news ! Up Up and away...
A bit of sarcasm meant to bring Joy to the Season! LOL Great news.
Who Bottles for PURA? Anybody know how much ALKM is involved?
MIRAMAR, FL -- November 26, 2018 -- InvestorsHub NewsWire -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced an agreement with Puration, Inc. (USOTC: PURA) to develop and produce NuGenerex CBD HydroHealth High Alkaline Water. The CBD used in the NuGenerex CBD HydroHealth product line will be exclusively derived from industrial hemp using a patented extraction process that yields ultra-purified and characterized CBD formulations. Generex plans to build on Puration’s track record in developing and marketing a successful line of CBD infused drinks in the sports nutrition market. Under the terms of the agreement, Puration will refine its patented extraction process to develop proprietary CBD formulations for NuGenerex CBD HydroHealth Water, which will be sold as therapeutic supplements for health maintenance in conditions in which CBD therapy has shown promise including, arthritis, epilepsy, chronic pain, generalized anxiety, diabetes, and cancer. The FDA has already approved a formulation of CBD called EpidiolexÒ for childhood epilepsy. Generex CBD HydroHealth Water is the first of a planned product line of NuGenerex CBD therapies, from alkaline water formulations to salves and creams for pain management that will be marketed through our wholly-owned subsidiary NuGenerex Distribution Solutions. The agreement with Puration is an initial step in the development of a larger and more comprehensive strategy where Generex is exploring the possible acquisition of US Cannabis Health, a joint venture company that includes Puration’s participation with other innovators in the pursuit of developing new cannabinoid therapies.
“Subject to testing and corresponding regulatory approvals, we’re targeting a million-bottle launch of Generex CBD HydroHealth Water in 2019,” Said Joseph Moscato, Generex President & Chief Executive Officer. “Given the network of pharmacies Generex owns itself, we are confident we can achieve if not exceed our million-bottle launch target. Puration’s experience and the caliber of Puration’s underlying extraction technology combined with the recently updated production facilities of Puration’s co-packer, are instrumental in Generex’s plan to rapidly launch NuGenerex CBD HydroHealth Water.”
“We are especially excited about Puration’s patented extraction technology that enables us to explicitly define and characterize the CBD and cannabinoid content of hemp extracts to develop proprietary, patented formulations for NuGenerex”, said Jason Terrell, MD, Chief Medical and Scientific Officer of Generex; “Through NuGenerex Distribution Solutions, we have the consumer connections, technology, and HIPAA compliant systems that will enable us to compile real world evidence on the safety and effectiveness of our NuGenerex CBD products for health maintenance in a variety of chronic conditions.”
“In anticipation of the agreement announced today with Generex, we have already been working on new CBD extracts to support Generex’s therapeutic objectives.” Said Brian Shibley, CEO of Puraiton, Inc. “With our US Cannabis Health partners, we are confident in the potential of the new extracts to meet and exceed Generex’s expectations. We are honored to be engaged by a company the caliber of Generex on this exciting project.”
About Generex Biotechnology Corporation
Generex is a strategic, diversified healthcare holdings company with offerings in a variety of services, diagnostics, Health devices, and pharmaceutical development.
The Company’s direct-to-patient services support its strategy of all-inclusive access to doctors, diagnostics, therapeutics, and additional health-related services to greatly improve the patient experience in receiving care.
On the provider side, Generex’s management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care.
Revenue from the Company’s subsidiaries will support clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics based on stimulating critical members of the immune response, known as T helper cells, and its proprietary buccal administration of insulin.
Cautionary Note Regarding Forward-Looking Statements
This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.
Contact:
Generex Biotechnology Corporation
Joseph Moscato
646-599-6222
Todd Falls
800-391-6755 Extension 222
investor@generex.com
Russo Partners
Investor / Media Contacts:
Alex Fudukidis
(646) 942-5632
alex.fudukidis@russopartnersllc.com
Caroline Cunningham
(212) 845-4292
Caroline.Cunningham@russopartnersllc.com
I'm a dog she's just another bitch! Well not anymore she uses Actipatch... lol JK
Just a sweet girlfriend who nags once a month. It was great to see her happy before the cocktails kicked in.
Believe me it works for having a happy girlfriend just as much as a happy wife, and daughters for those blessed with a house full of them.
The more who know the happier we are! :)
I need a cartoon to go with that one
Holy Cow Bielman do your numbers on this!
I know it helps a woman's monthly cramps and that alone is massive repeat business in the tens of millions of users.
I'd buy them for the women in my life, in fact have. I gave it to a girlfriend a few weeks ago, as a joke, I tossed it on her stomach while we were hanging out on the patio and she never gave it back.
She said it was a GOD SEND, and her horrible pain went away in about 30 minutes. She moved it around a few areas that hurt and I never saw that unit again. That is why I just bought 10 more!!
Worth every penny to see her smile.
I grew up with 3 women in the house that should make me a male expert on what men have to endure. (LOL) Trust me you would spend the money just to get some sleep.
Lots of love to all the women in my life, we just want you happy ;)
Men step up and see for yourself and get a little "Peace on Earth" this holiday season. Women WILL tell their girlfriends of Actipatches wonders and this will be on fire.
It works on migraines too... Just think no more "Honey I have a headache) either!! Ha
It's a great grass roots approach to achieve peace on earth at the home front and becoming Biellionaires a whole lot faster.
A little fun for thought.
Happy Holidays from Ghost Dog!
Go $Biel$
Over 7 million reasons to be ready to hold on!
I love these things they work for me and know they do for others.
I bought 10 in the past 3 days and referred several friends (old farts) having knee surgery. Why not, right?
A good bottle of wine or a dinner out cost more than one of these miracle devices. What does anyone have to loose but pain from trying one?
You won't hear about any overdoses on the Actipatch!!! Go $BIEL$
Man I need some Alkame water to wash all that turkey down!!
Happy Thanksgiving...
Remember to do a thorough cavity search on your Turkey, they don't come pre-stuffed.
I hold a long 2 million plus and growing. I'd buy the whole company if I had 2 million bucks cash! This is cheap cheap cheap cheap.
I became a founding ambassador because I believe in this company and got a great domain. When phase 2 kicks in the early birds will make bank.
I think a lot of folks took the week off from trading to stuff their mouths instead of wallets.
GLTA
Jag our ex's must have been related! LOL
Nice post and I have had the coolaid! Tried Pura and its a real product on the shelves so are the Bell food products. It takes time, I know I have a product in grocery stores now nation wide (1400 plus and growing). 6 years in the making and still, little to no return. Yet I believe because there is an actual product consumers love and we are making deals. That said.
Alkame bottles and co-packs many products people love. They own the technology, facility and who knows what else. Robert Earkle is NOT DUMB he knows his business well. Those who complain know little (IMO) about building a multi-faceted company. You have to dance with the symphony not bounce around to hip hop. In other words chill out and relax.
Don't like the stock sell. Like it? Put a little in your retirement account. Mark this post. This will be bought out buy a big name it's inevitable with the pending market cap potential for world wide distribution. It's just a matter of when, I doubt anytime soon. Earkle is just now getting started.
I BIEL-IEVE, I BIEL-IEVE, I BIEL-IEVE that BIEL will relieve all your financial pains!!!! Buy now or chase the dragon! Ha :)
Grass roots helps folks, share, talk,give as gifts, send to old folks with RA and watch them bust a move again. RA is what the VA approved Actipatch for.
And you bet I would love to see this at .19 or higher by the end of next year or waaaaay sooner. This is really getting exciting.
Probably why CVS is already on the bandwagon. 200 store roll out prior to announcement of FLA lawsuit. Hmmmm They are already on it folks.
Buy up BIEL because I think this will continue to go up from here. Maybe not 1000% by next year end 2019. but I am confident in the next few years this will make anyone with substantial shares a very very happy Bielster~ and I can buy Ghost a new dog house.
https://ih.advfn.com/p.php?pid=nmona&article=78686812&_ga=2.259411146.1348849132.1541351040-1304999045.1539212801
I think they should talk...! Maybe even start dating ;)
Onsite power, heavy oil, water recycle, etc.. Just what PQEFF needs as a strategic partner of sorts. IMO.
Let me know if I am thinking wrong but I have made a nice little profit on PQEFF and think they are just beginning and are a good long for any portfolio.
Takes time but at these prices it's cheap. Where will it be in 1 year, 5, 10, somethings take time to build. Imagine 100,000.BBPD in 5 to 10 years plus lease royalties. It's a big goal but it's very possible when the big producers have let them test the technology and get the bugs out.
Open for discussion !!!